BeneVir Biopharm, Inc. — Form D
BeneVir Biopharm, Inc. of Gaithersburg, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-16. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-16
- Form: D
- Accession: 0001626108-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $2.0M
- Investors: 1
- Date of first sale: 2017-10-17
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-298906
Issuer
- Name: BeneVir Biopharm, Inc.
- CIK: 0001626108
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 708 Quince Orchard Road, Gaithersburg, MD, 20878
- Phone: 240-474-5280
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Matthew Charles Mulvey | Director | Gaithersburg, MD |
| Cherine Charles Plumaker | Director | Gaithersburg, MD |
| David Charles Present | Director | Gaithersburg, MD |
| Katherine Ann Sacksteder | Director | Gaithersburg, MD |
| Matthew Charles Mulvey | Executive Officer | Gaithersburg, MD |
| Katherine Ann Sacksteder | Executive Officer | Gaithersburg, MD |
| David Charles Kirn | Director | Gaithersburg, MD |
Other filings by this issuer (3)
More